• 1
    Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425434.
  • 2
    Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 1125.
  • 3
    Butcher EC. Cellular and molecular mechanisms that direct leukocyte traffic. Am J Pathol 1990; 136: 311.
  • 4
    Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps of specificity and diversity. Cell 1991; 67: 10331036.
  • 5
    Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537544.
  • 6
    Pardi R, Inverardi L, Bender JR. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol Today 1992; 13: 224230.
  • 7
    Calvin RB. Cellular and molecular mechanisms of allograft rejection. Annu Rev Med 1990; 361375.
  • 8
    Krensky AM, Weiss A, Crabtree G, Davis MM, Parham P. T-lymphocyte–antigen interactions in transplant rejection. N Engl J Med 1990; 322: 510517.
  • 9
    Rieder H, Meyer zum Büschenfelde KH, Ramadori G. Functional spectrum of sinusoidal endothelial liver cells; filtration, endocytosis, synthetic capacities and intercellular communication. J Hepatol 1992; 15: 237250.
  • 10
    Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989; 2: 11221125.
  • 11
    Steinhoff G, Behrend M, Wonigeit K. Expression of adhesion molecules on lymphocytes/monocytes and hepatocytes in human liver grafts. Human Immunol 1990; 28: 123128.
  • 12
    Behrend M, Steinhoff G, Wonigeit K, Pichlmayr R. Pattern of adhesion molecule expression in human liver allografts. Transplant Proc 1991; 23: 14191420.
  • 13
    Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia: lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct ditribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am J Pathol 1993; 142: 481488.
  • 14
    Scoacez JY, Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology 1991; 14: 789797.
  • 15
    Volpes R, Van Den Oord JJ, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992; 15: 269275.
  • 16
    Williams AF, Barclay AN. The immunoglobulin superfamily: domains for cell surface recognition. Annu Rev Immunol 1988; 6: 381405.
  • 17
    Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 12701274.
  • 18
    Makgoba MW, Sanders ME, Shaw S. The CD2-LFA-3 and LFA-1-ICAM-1 pathways: relevance to T-cell recognition. Immunol Today 1989; 10: 417422.
  • 19
    de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counterreceptor for LFA-1. J Exp Med 1991; 174: 253267.
  • 20
    Seth R, Salcedo R, Patarroyo M, Makgoba MW. ICAM-2 peptides mediate lymphocyte adhesion by binding to CD11a/CD18 and CD49d/CD29 integrins. FEBS Lett 1991; 282: 193196.
  • 21
    de Fougerolles AR, Springer TA. Intercellular adhesion molecules 3: a third adhesion counter-receptor for lymphocyte function–associated molecule-1 on resting lymphocytes. J Exp Med 1992; 175: 185190.
  • 22
    Osborn L, Hession C, Tizard R, Vasallo C, Luhowkyj S, Chi-Rosso G, Lobb R. Direct expression cloning of vascular cell adhesion molecule 1 (VCAM-1), a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 12031211.
  • 23
    Rice GE, Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. J Exp Med 1990; 171: 13691374.
  • 24
    Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577584.
  • 25
    Oppenheimer-Marks N, Davis LS, Tompkins Bogue D, Ramberg J, Lipsky PE. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T-lymphocytes. J Immunol 1991; 147: 29132921.
  • 26
    Hercend T, Griffin JD, Besussan A, Schmidt RE, Edson MA, Brennan A, Murray C, et al. Generation of monoclonal antibodies to a human natural killer clone: characterization of two natural killer associated antigens, NKH1A and NKH2 expressed on subsets of large granular lymphocytes. J Clin Invest 1985; 75: 932943.
  • 27
    Lanier LL, Le AM, Civin EI, Loken MR, Phillips JR. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK-cells and cytotoxic T lymphocytes. J Immunol 1986; 136: 44804486.
  • 28
    Simmonds DL, Walker C, Power C, Pigott R. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 1990; 171: 21472152.
  • 29
    Albeda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 1991; 114: 10591068.
  • 30
    Camerini D, James SP, Stamenkovic I, Seed B. Leu8/TQ 1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature 1989; 342: 7882.
  • 31
    Tedder TF, Penta AC, Levine HB, Feedman AS. Expression of the human leukocyte adhesion molecule, LAM-1: identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 1990; 144: 532540.
  • 32
    Kishimoto TK, Jutila MA, Butcher EC. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci USA 1990; 87: 22442248.
  • 33
    Bührer C, Berlin C, Thiele HG, Hamann A. Lymphocyte activation and expression of the human leukocyte-endothelial cell adhesion molecule 1 (Leu8/TQ1 antigen). Immunology 1990; 71: 442448.
  • 34
    Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell 1991; 66: 921933.
  • 35
    Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA Jr, Tedder TF. Leukocyte adhesion molecule-1 (LAM-1, L-SELECTIN) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991; 147: 25652573.
  • 36
    Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 92389242.
  • 37
    Leeuwenberg JFM, Von Asmuth EJU, Jeunhomme TMAA, Buurman WA. IFN-γ regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells J Immunol 1990; 145: 21102114.
  • 38
    Phillips ML, Nudelman E, Gaeta FCA, Perez M, Singhal AK, Hakumori SL, Paulson JC. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990; 250: 11301132.
  • 39
    Polley MJ, Phillips ML, Wayner E, Nudelman E, Sinhal AK, Hakomori S, Paulson JC. CD 62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci 1991; 88: 62246228.
  • 40
    Tiemeyer M, Swiedler SJ, Ishihara M, Moreland M, Schmweingruber H, Hirtzer P, Brandley BK. Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 88: 11381142.
  • 41
    McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP 140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 9299.
  • 42
    Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 77687771.
  • 43
    Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343: 757760.
  • 44
    Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859873.
  • 45
    Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223234.
  • 46
    Duivestijn AM, Horst E, Pals ST, Rouse BN, Steere AC, Picker LJ, Meijer CJLM, et al. High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 1988; 130: 147155.
  • 47
    Haynes BF, Telen MJ, Hale LP, Denning SM. CD44: a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10: 423428.
  • 48
    Shimizu Y, van Seventer GA, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T-cell adhesion and activation. J Immunol 1989; 143: 24572463.
  • 49
    Schlitt HJ, Nashan B, Ringe B, Bunzendahl H, Wittekind C, Wonigeit K, Pichlmayr R. Differentiation of liver graf dysfunction by transplant aspiration cytology. Transplantation 1991; 51: 786793.
  • 50
    Mason DY, Woolston RE. Double immunoenzymatic labelling. In: BullockGR, PetruszP, eds. Techniques in immunocytochemistry. New York: Academic Press, 1982: 135153.
  • 51
    Steinhoff G, Wonigeit K, Pichlmayr R. Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 1988; 45: 394401.
  • 52
    Steinhoff G, Wonigeit K, Harpprecht J, Johnson JP, Pichlmayr R. Expression of donor and recipient class I and class II major histocompatibility complex antigens in human liver grafts. Transplant Proc 1987; 19: 35613564.
  • 53
    Steinhoff G. Major histocompatibility complex antigens in human liver transplants. J Hepatol 1990; 11: 915.
  • 54
    KnappW, DörkenB, GilksWR, ReiberPM, SchmidtRE, SteinH, Von dem BorneAEG, eds. Leucocyte typing IV. Oxford: Oxford University Press, 1989.
  • 55
    Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, Hodgdon JC, et al. An alternative pathway of T-cell activation: a functional role of the 50 KD T11 sheep erythrocyte receptor protein. Cell 1984; 36: 897906.
  • 56
    Wellicome SM, Thornhill MD, Thomas DS, Pitzalis C, Lanchbury JS, Panayi GS, Haskard DO. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, II-1 or lipopolysaccharide. J Immunol 1990; 144: 255865.
  • 57
    Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JSS, Kyan-Aung U, Haskard DO. Tumor necrosis factor combines IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells: the contribution of vascular cell adhesion molecule-1 dependent and independent binding mechanisms. J Immunol 1991; 146: 592598.
  • 58
    Todd RF III, Schlossman SF. Utilization of monoclonal antibodies in the characterization of monocyte-macrophage differentiation antigens. In: BellantiJA, HerscowitzHB, eds. The reticuloendothelial system. Vol 6. New York: Plenum Press, 1984; 87112.
  • 59
    Hemler ME, Jacobson JG, Brenner MB, Mann D, Strominger JL. VLA-1: a T cell surface antigen which defines novel late stage of human T cell activation. Eur J Immunol 1985; 15: 502508.
  • 60
    Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common β subunits. J Cell Biol 1987; 105: 18731884.
  • 61
    Thornhill MH, Kyan-Aung U, Haskard DO. IL-4 increases human endothelial cell adhesiveness for T-cells but not for neutrophils. J Immunol 1990; 144: 30603065.
  • 62
    Smith MEF, Thomas JA. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 1990; 43: 893900.
  • 63
    Rubinstein D, Roska AK, Lipsky PE. Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogenic T lymphocytes. J Immunol 1986; 137: 18031810.
  • 64
    Keizer GD, Visser W, Vleim M, Fidgor DG. A monoclonal antibody (NKI-L16) directed against a unique epitope on the alpha chain of human leukocyte function associated antigen 1 induces homotypic cell-cell interaction. J Immunol 1988; 140: 13931400.
  • 65
    Chan BMC, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME. Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains. Cell 1992; 68: 10511060.
  • 66
    Pulido R, Elices MJ, Campanero MR, Osborn L, Schiffer F, Garcia-Pardo A, Lobb R, et al. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4: correlation with distinct alpha4 epitopes. J Biol Chem 1991; 266: 1024110245.
  • 67
    Schwartz BR, Wayner EA, Carlos TM, Ochs HD, Harlan JM. Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest 1990; 85: 20192022.
  • 68
    Shimizu Y, VanSeventer GA, Horgan KJ, Shaw S. Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 1990; 345: 250253.
  • 69
    Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, Derse-Anthony CP, Klunk D, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991; 173: 15531556.
  • 70
    Issekutz TB. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody: a likely role for VLA-4 in vivo. J Immunol 1991; 147: 41784184.
  • 71
    Bissel M. Lipocyte activation and hepatic fibrosis. Gastroenterology 1992; 102: 18031805.
  • 72
    Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 1990; 10: 2029.
  • 73
    Wight DGD. Pathology of rejection. In: CalneRY, ed. Liver transplantation. New York: Grune & Stratton, 1979; 247.
  • 74
    Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524527.
  • 75
    Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338: 8384.
  • 76
    Blumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Cell subset responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigens. I. The role of L3T4 + T cells in the development of allospecific cytotoxicity in hepatocyte sponge matrix allografts. Transplantation 1992; 53: 857862.
  • 77
    Blumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Cell subset responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigens. II. In vitro–generated “memory” cells to class I+ class II hepatocytes. Transplantation 1992; 53: 863868.
  • 78
    Picker LJ, Terstappen LWMM, Rott LS, Streeter PR, Stein H, Butcher EC. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 1990; 145: 32473255.
  • 79
    Cosimi AB, Conti D, Delmonico FL, Preffer FI, Wee SL, Rothlein R, Faanes R, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in non-human primates with renal allografts. J Immunol 1990; 144: 46044612.
  • 80
    Flavin T, Ivens K, Rothlein R, Faanes R, Clayberger C, Billingham M, Starnes VA. Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys. Transplant Proc 1991; 23: 533534.
  • 81
    Horgan MJ, Wright SD, Malik AB. Antibody against leukocte integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol 1990; 259: 315319.
  • 82
    Simpson P, ToddIII JRF, Fantone JC, Mickelson JM, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988; 81: 624629.
  • 83
    Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. Transplantation 1992; 53: 957978.
  • 84
    Simpson PJ, Michalson J, Fatane JC, Gallagher KP, Lucchesi BR. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation. J Pharmacol Exp Ther 1988; 244: 619624.
  • 85
    Howard TK, Klintmalm GB, Cofer JB, Hubeng BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 9: 103107.
  • 86
    Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364375.